AI Article Synopsis

  • The study aimed to evaluate the anti-inflammatory effects of moxibustion on rheumatoid arthritis (RA) by analyzing its impact on Annexin 1 expression and the phospholipase A2 signaling pathway.
  • Thirty male rats were divided into five groups to test various treatments, including moxibustion and Annexin 1 interference, following the induction of RA with Freund's complete adjuvant.
  • Results indicated that moxibustion enhanced Annexin 1 levels, reduced inflammation, and positively influenced various inflammatory markers in the rats, suggesting its potential therapeutic role in RA.

Article Abstract

Objective: To determine whether moxibustion had an anti-inflammatory effect on rheumatoid arthritis (RA) by regulating Annexin 1 expression and interfering with the phospholipaseA2 signaling pathway.

Methods: Thirty male Sprague-Dawley rats were randomly categorized into five groups (six rats per group): blank control (CON) group, RA model (RA) group, moxibustion (MOX) group, Annexin 1 lentiviral intervention (RNAi-Anxa1) group, and Annexin 1 lentiviral intervention + moxibustion (RNAi-Anxa1 + MOX) group. The rats in the RNAi-Anxa1 and the RNAi-Anxa1 + MOX groups were injected with the lentiviral vector-mediated RNAi-Anxa1 into the rat foot pad. An experimental RA rat model was established by injecting Freund's complete adjuvant (FCA) into the RA, MOX, RNAi-Anxa1, and RNAi-Anxa1 + MOX groups. Rats in the MOX and RNAi-Anxa1 + MOX groups received moxibustion treatment. After modeling, using moxibustion "Shenshu (BL23)" and "Zusanli (ST36)", each point is 5 times, bilateral alternating, once a day, 6 times for a course of treatment, between the courses of rest for a one day. A total of three treatment courses were conducted. Both bilateral pad thicknesses were measured using Vernier calipers on experimental days 1, 7, 14, 21, and 28. The expression of cPLA2α signaling in the synovium of diseased joints was observed using Western blot. The pathology of the rat ankle synovium was observed using hematoxylin-eosin (HE) staining. Interleukin (IL)-1β, IL-10, prostaglandin E2 (PGE2), and leukotriene B4 (LTB4) were detected using enzyme-linked immunosorbent assay.

Results: Moxibustion increased the levels of Annexin 1 and decreased the inflammatory response in rats with RA. After increasing the expression of Annexin 1, the phosphorylated expression of cPLA2α was inhibited, the serum levels of IL-1β, PGE2, and LTB4 decreased, and the level of IL-10 increased. In moxibustion treated RA rats after the Annexin 1 lentiviral intervention, the serum levels of IL-1β, PGE2, LTB4, and IL-10 were almost unchanged.

Conclusion: Moxibustion enhanced the negative regulation of the cPLA2α signaling pathway, increased the synovial Annexin 1 expression, inhibited the cPLA2α signaling pathway, indirectly inhibited the expression of downstream inflammatory factors, and played a role in reducing inflammation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11337253PMC
http://dx.doi.org/10.19852/j.cnki.jtcm.20240610.003DOI Listing

Publication Analysis

Top Keywords

rnai-anxa1 mox
16
annexin lentiviral
12
lentiviral intervention
12
mox groups
12
cpla2α signaling
12
moxibustion
9
rheumatoid arthritis
8
phospholipasea2 signaling
8
annexin
8
annexin expression
8

Similar Publications

Article Synopsis
  • The study aimed to evaluate the anti-inflammatory effects of moxibustion on rheumatoid arthritis (RA) by analyzing its impact on Annexin 1 expression and the phospholipase A2 signaling pathway.
  • Thirty male rats were divided into five groups to test various treatments, including moxibustion and Annexin 1 interference, following the induction of RA with Freund's complete adjuvant.
  • Results indicated that moxibustion enhanced Annexin 1 levels, reduced inflammation, and positively influenced various inflammatory markers in the rats, suggesting its potential therapeutic role in RA.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!